<DOC>
	<DOCNO>NCT01503216</DOCNO>
	<brief_summary>The aim study investigate bioavailability vitamin D2 D3 measure increase specific hydroxy form serum ( 25 ( OH ) D2 25 ( OH ) D3 , respectively , total 25 ( OH ) D .</brief_summary>
	<brief_title>Safety Bioefficacy Vitamin D2 Vitamin D3</brief_title>
	<detailed_description>Study design : Human volunteer receive supplement contain either vitamin D2 D3 period 8 week . At baseline , 4 week 8 week , 25 ( OH ) D2 , 25 ( OH ) D3 total 25 ( OH ) D measure serum main outcome variable . Additional outcome variable Ca concentration serum , PTH concentration serum , ambulatory blood pressure heart rate , renin expression peripheral mononuclear cell . Groups/Cohorts Assigned Interventions 1 . Placebo group 2 . Vitamin D2-group Daily treatment vitamin d2-supplements ( contain 2000 IU per capsule ) 3 . Vitamin D3-group Daily treatment vitamin d3-supplements ( contain 2000 IU per capsule )</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>18 year healthy supplementation vitamin calcium hypercalcemia hypercalciuria chronical illness ( diabetes , kidney disease , cardiovascular disease ) serumcreatinine 115 mmol/l pregnancy breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>randomize control trial</keyword>
	<keyword>vitamin D</keyword>
	<keyword>bioavailability</keyword>
</DOC>